FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909759958> ?p ?o ?g. }

• W2909759958 endingPage "160" @default.
• W2909759958 startingPage "150" @default.
• W2909759958 abstract "Study Objective Evidence on the cardiotoxicity of nonaspirin nonsteroidal antiinflammatory drugs ( NSAID s), particularly diclofenac and the newer selective cyclooxygenase ( COX )‐2 inhibitors, has accumulated over the last decade. Our objective was to examine whether the use of NSAID s in the Nordic countries changed with the emerging evidence, regulatory statements, and clinical guidelines advocating caution for the use of specific NSAID s. Design Drug utilization study. Data Sources Nationwide wholesale statistics and prescription registries in Denmark, Finland, Iceland, Norway, and Sweden (2000–2016). Measurements and Main Results Our main outcome measures were yearly total sales, expressed as number of sold defined daily doses ( DDDs )/1000 inhabitants/day, and yearly prevalence of prescription use, expressed as number of prescription users per 1000 inhabitants. The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. Total sales of NSAID s increased in all countries and were highest in Iceland, with 74.3 DDD s/1000 inhabitants/day sold in 2016, followed by Finland (73.9), Sweden (54.4), Norway (43.8), and Denmark (31.8). Diclofenac use declined after 2008 in all countries but remained the most widely prescribed NSAID in Norway, with 63 prescription users/1000 inhabitants in 2016. Diclofenac sales also remained high in Iceland (12.7 DDD /1000 inhabitants/day), Norway (8.1), and Sweden (7.8). Since its introduction in 2003, the use of etoricoxib, a newer selective COX ‐2 inhibitor, increased in all countries except Denmark, with highest sales in Finland (6.7 DDD /1000 inhabitants/day in 2016). Conclusion Sales and prescription patterns of NSAID s in the Nordic countries has changed along with the accumulating evidence for the cardiovascular risks of specific NSAID s. However, given existing evidence on the cardiovascular risks associated with the use of diclofenac and etoricoxib, the persistent high use of diclofenac in Iceland, Norway, and Sweden, the persistent over‐the‐counter availability of diclofenac in Norway and Sweden, and the increasing use of etoricoxib in most of the Nordic countries pose a cardiovascular health concern." @default.
• W2909759958 created "2019-01-25" @default.
• W2909759958 creator A5050587534 @default.
• W2909759958 creator A5051403615 @default.
• W2909759958 creator A5053368057 @default.
• W2909759958 creator A5072859924 @default.
• W2909759958 creator A5086208075 @default.
• W2909759958 creator A5086353678 @default.
• W2909759958 creator A5089401828 @default.
• W2909759958 date "2019-02-01" @default.
• W2909759958 modified "2023-10-03" @default.
• W2909759958 title "Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization Study" @default.
• W2909759958 cites W1599185368 @default.
• W2909759958 cites W1984658180 @default.
• W2909759958 cites W1990165855 @default.
• W2909759958 cites W1990824360 @default.
• W2909759958 cites W1993961357 @default.
• W2909759958 cites W2010865202 @default.
• W2909759958 cites W2021075645 @default.
• W2909759958 cites W2046175499 @default.
• W2909759958 cites W2088179895 @default.
• W2909759958 cites W2117784691 @default.
• W2909759958 cites W2134634779 @default.
• W2909759958 cites W2143981995 @default.
• W2909759958 cites W2157021912 @default.
• W2909759958 cites W2168021466 @default.
• W2909759958 cites W2298123402 @default.
• W2909759958 cites W2538943279 @default.
• W2909759958 cites W2610395923 @default.
• W2909759958 cites W2613818341 @default.
• W2909759958 cites W2791979091 @default.
• W2909759958 cites W2892271400 @default.
• W2909759958 cites W4232359159 @default.
• W2909759958 doi "https://doi.org/10.1002/phar.2217" @default.
• W2909759958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30636337" @default.
• W2909759958 hasPublicationYear "2019" @default.
• W2909759958 type Work @default.
• W2909759958 sameAs 2909759958 @default.
• W2909759958 citedByCount "18" @default.
• W2909759958 countsByYear W29097599582019 @default.
• W2909759958 countsByYear W29097599582020 @default.
• W2909759958 countsByYear W29097599582021 @default.
• W2909759958 countsByYear W29097599582022 @default.
• W2909759958 countsByYear W29097599582023 @default.
• W2909759958 crossrefType "journal-article" @default.
• W2909759958 hasAuthorship W2909759958A5050587534 @default.
• W2909759958 hasAuthorship W2909759958A5051403615 @default.
• W2909759958 hasAuthorship W2909759958A5053368057 @default.
• W2909759958 hasAuthorship W2909759958A5072859924 @default.
• W2909759958 hasAuthorship W2909759958A5086208075 @default.
• W2909759958 hasAuthorship W2909759958A5086353678 @default.
• W2909759958 hasAuthorship W2909759958A5089401828 @default.
• W2909759958 hasBestOaLocation W29097599582 @default.
• W2909759958 hasConcept C23276603 @default.
• W2909759958 hasConcept C2426938 @default.
• W2909759958 hasConcept C2776214540 @default.
• W2909759958 hasConcept C2776865356 @default.
• W2909759958 hasConcept C2778484676 @default.
• W2909759958 hasConcept C2779751750 @default.
• W2909759958 hasConcept C2779826273 @default.
• W2909759958 hasConcept C2780035454 @default.
• W2909759958 hasConcept C71924100 @default.
• W2909759958 hasConcept C98274493 @default.
• W2909759958 hasConcept C99454951 @default.
• W2909759958 hasConceptScore W2909759958C23276603 @default.
• W2909759958 hasConceptScore W2909759958C2426938 @default.
• W2909759958 hasConceptScore W2909759958C2776214540 @default.
• W2909759958 hasConceptScore W2909759958C2776865356 @default.
• W2909759958 hasConceptScore W2909759958C2778484676 @default.
• W2909759958 hasConceptScore W2909759958C2779751750 @default.
• W2909759958 hasConceptScore W2909759958C2779826273 @default.
• W2909759958 hasConceptScore W2909759958C2780035454 @default.
• W2909759958 hasConceptScore W2909759958C71924100 @default.
• W2909759958 hasConceptScore W2909759958C98274493 @default.
• W2909759958 hasConceptScore W2909759958C99454951 @default.
• W2909759958 hasIssue "2" @default.
• W2909759958 hasLocation W29097599581 @default.
• W2909759958 hasLocation W29097599582 @default.
• W2909759958 hasLocation W29097599583 @default.
• W2909759958 hasOpenAccess W2909759958 @default.
• W2909759958 hasPrimaryLocation W29097599581 @default.
• W2909759958 hasRelatedWork W113449535 @default.
• W2909759958 hasRelatedWork W149558231 @default.
• W2909759958 hasRelatedWork W2000005227 @default.
• W2909759958 hasRelatedWork W2122120608 @default.
• W2909759958 hasRelatedWork W2606336619 @default.
• W2909759958 hasRelatedWork W2783428982 @default.
• W2909759958 hasRelatedWork W2807335144 @default.
• W2909759958 hasRelatedWork W2909759958 @default.
• W2909759958 hasRelatedWork W2972921185 @default.
• W2909759958 hasRelatedWork W4214780175 @default.
• W2909759958 hasVolume "39" @default.
• W2909759958 isParatext "false" @default.
• W2909759958 isRetracted "false" @default.
• W2909759958 magId "2909759958" @default.
• W2909759958 workType "article" @default.